Introduction {#Sec1}
============

Neuroticism is a personality trait often described in individuals with glaucoma (GLC), and has been suggested to be a possible cause of fluctuations in intraocular pressure \[[@CR1]\]. Early studies have described patients with GLC as anxious, overconscientious \[[@CR2]\], depressive, hysterical, meticulous, and perfectionists \[[@CR3]--[@CR6]\]. Recent studies using the five-factor model of personality \[[@CR7]\], which describes human personality as a combination of extraversion, agreeableness, conscientiousness, neuroticism, and openness, have suggested that patients with GLC have a greater level of neuroticism than patients with cataracts \[[@CR8]\], indicating that patients with GLC might have a neurotic personality.

However, such a neuroticism-featuring personality is not necessarily representative of the total population of patients with GLC. A previous study has revealed that adherence and persistence with medication in patients with GLC was lower than that for of individuals with other chronic diseases, such as diabetes, dyslipidemia, and osteoporosis \[[@CR9]\]. In that study, over 50% of patients with GLC stopped their medications within 6 months \[[@CR9]\]. Another study has suggested that this trend was similar regardless of the class of medication, for example, with prostaglandins, alpha-agonists, and beta-blockers \[[@CR10]\]. This suggests that there is likely to be a population of patients suffering from GLC who discontinue regular visits an ophthalmologist and are thus are invisible to healthcare workers. As a result, little will also be known about their neuroticism personality trait.

In the present study, the authors compared the level of neuroticism between a population of patients with GLC who have discontinued their visits to ophthalmological clinics and a population who maintain their regular visits.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

Patients with glaucoma were recruited from a consumer investigator database (Macromill, Inc., Tokyo, Japan). Invitation letters were sent to eligible candidates. After the study protocol was presented at the dedicated website of Macromill, Inc., informed consent was obtained by clicking an agreement button. All enrolled patients had to have been diagnosed with GLC and they had to have received prescriptions by ophthalmologists before participation in the present study. Diagnosis, type of GLC, and prescription information was self-disclosed by the participants. This study protocol was approved by the Ethics Committee of Jikei University School of Medicine.

Assessment Procedures {#Sec4}
---------------------

All assessments were conducted through the dedicated website of Macromill, Inc. Participants were assessed on their duration of visits to ophthalmologists: 0 = regularly visits, 1 = discontinued for less than 1 month, 2 = discontinued for 1--3 months, 3 = discontinued for 3--6 months, and 4 = discontinued for over 6 months. All participants completed the assessment procedures and were subsequently assigned to two groups based on the continued duration of their visits to their ophthalmologists. These groups were referred to as the *Discontinued* group (participants rated as 1, 2, 3, and 4) and the *Regular Visitor* group (those rated as 0). Thus 'discontinued' was defined as the duration (or number of days) from an appointment day when the participants were supposed to but did not visit their ophthalmologist. Stratified sampling was conducted by three age groups (40--49 years old, 50--59 years old, and 60 years old and over), as well as gender groups (male and female). The sample size was adopted from the previous study by Mabuchi et al. \[[@CR8]\]. All patients underwent a personality evaluation using the Japanese version of the ten-item personality inventory (TIPI-J).

Japanese Version of the Ten-Item Personality Inventory (TIPI-J) {#Sec5}
---------------------------------------------------------------

The ten-item personality inventory (TIPI) is a questionnaire specifically used to evaluate the 'Big Five' personality traits \[[@CR11]\]. The Big Five personality traits comprise five factors of personality traits, referred to as extraversion, agreeableness, conscientiousness, neuroticism, and openness to experience \[[@CR12]\].

TIPI can be applied to large-scale research due to the minimal number of items to be answered as compared with other authorized questionnaires, such as the revised neuroticism-extraversion-openness personality inventory (NEO PI-R), comprising 240 items, and the five-factor personality questionnaire 50 (FFPQ-50), comprising 50 items. The Japanese version of TIPI (TIPI-J) has a validity equal to the FFPQ-50 \[[@CR13]\], indicating that the TIPI-J questionnaire specifically evaluates the Big Five personality traits. TIPI items are rated from 1 (strongly disagree) to 7 (strongly agree) by the participants. The TIPI items are as follows:Extraverted, enthusiasticCritical, quarrelsomeDependable, self-disciplinedAnxious, easily upsetOpen to new experiences, complexReserved, quietSympathetic, warmDisorganized, carelessCalm, emotionally stableConventional, uncreative.

Data Analysis {#Sec6}
-------------

All data analyses were performed with R statistical environment 3.2.3 (R Development Core Team) and Prism 6.0 software (GraphPad Software Inc., San Diego, CA, USA). To evaluate each personality trait, the authors adopted the following calculation \[[@CR13]\]: extraversion: item 1 + (8 − item 6); agreeableness: (8 − item 2) + item 7; conscientiousness: item 3 + (8 − item 8); neuroticism: item 4 + (8 − item 9); and openness to new experiences: item 5 + (8 − item 10). To evaluate the personality profile characteristics of the *Discontinued* group, the authors performed a two-sample *t* test between the *Discontinued* and *Regular Visitor* groups for each sub-item score from TIPI-J. Statistical significance was set at less than 5% for each sub-item.

To assess the relationship between personality trait and the duration of non-visits, the authors performed correlation analysis between the sub-item(s) from TIPI-J that showed statistical significance by two-sample *t*-test and the frequency of non-visits to ophthalmologists in the *Discontinued* group. Spearman's rank correlation coefficient (*ρ*) was used to examine the relationship between the personality trait sub-item(s) and the duration of non-visits. Statistical significance was set at less than 5%.

Results {#Sec7}
=======

Invitations were sent to 494 study candidates, and 373 individuals spontaneously visited the dedicated website of Macromill, Inc. No individuals declined to participate in the study, thus 373 patients with GLC were recruited to the study. The response rate, calculated as the number of participants enrolled relative to the number of invitations sent, was 75.5%.

Patient Demography {#Sec8}
------------------

The *Discontinued* group consisted of 186 participants and the *Regular Visitor* group consisted of 187 participants. The mean age of patients in the *Discontinued* group was significantly higher than that of patients in the *Regular Visitor* group (58.7 ± 10.1 years vs. 56.3 ± 10.0, respectively, *p* = 0.02; Table [1](#Tab1){ref-type="table"}). No significant difference was found in the gender ratio of the two groups (74.5% male vs. 50.3% male, *P* = 0.18; Table [1](#Tab1){ref-type="table"}). The median non-visit duration of the *Discontinued* group was over 6 months.Table 1Comparison of demography between *Discontinued* and *Regular Visitors* to ophthalmologists in patients with glaucoma*Discontinued* group*Regular Visitor* group*P* value^a^*N*188187Male gender (%)74.550.30.18Age (mean ± SD) (years)58.7 ± 10.156.3 ± 10.00.02Duration of non-visits to ophthalmologist (mode)\>6 monthsN/ANo significant difference was found in the gender ratio between the *Discontinued* group (those patients who have not visits an ophthalmologist for the last 6 months) and the *Regular Visitors* group (those patients who continue to make regular visits to ophthalmologists); a significant difference was found in the mean age of patients between the two groups*N/A* not applicable, *SD* standard deviation^a^Two-sample *t*-test was performed for age, and Chi square test for gender ratio between the *Discontinued* and *Regular Visitor* groups to ophthalmologists in patients with glaucoma. Statistical significance of both tests was set at less than 5%

Comparison of Sub-items from TIPI-J Between *Discontinued* and *Regular Visitor* Groups {#Sec9}
---------------------------------------------------------------------------------------

The mean neuroticism score from the TIPI-J for the *Discontinued* group was significantly lower than that for the *Regular Visitor* group (7.63 ± 2.23 vs. 8.23 ± 2.21, respectively, *p* = 0.01; Table [2](#Tab2){ref-type="table"}). No significant difference was found in extraversion, agreeableness, conscientiousness, and openness to new experiences scores between the *Discontinued* and the *Regular Visitor* groups (Table [2](#Tab2){ref-type="table"}). The scores in the *Discontinued* group were almost identical to those in the *Regular Visitor* group (7.53 ± 2.48 vs. 7.28 ± 2.48 for extraversion, 9.63 ± 2.01 vs. 9.74 ± 2.02 for agreeableness, 8.39 ± 2.28 vs. 8.54 ± 2.37 for conscientiousness, and 7.93 ± 2.03 vs. 7.88 ± 2.15 for openness to new experiences, respectively; Table [2](#Tab2){ref-type="table"}).Table 2Comparison of sub-item scores from the TIPI-J between the *Discontinued* and *Regular Visitors* groupsSub-items from TIPI-J*Discontinued* group*Regular Visitor* group*P* value^a^(Mean ± SD)(Mean ± SD)Extraversion7.53 ± 2.487.28 ± 2.480.32Agreeableness9.63 ± 2.019.74 ± 2.020.60Conscientiousness8.39 ± 2.288.54 ± 2.370.51Neuroticism7.63 ± 2.238.23 ± 2.210.01Openness to experiences7.93 ± 2.037.88 ± 2.150.25The *Discontinued* group (those patients who have not visits an ophthalmologist for the last 6 months) had a significantly higher score only in the neuroticism sub-item when compared to the *Regular Visitor* group (those patients who continue to make regular visits to ophthalmologists)*SD* standard deviation, *TIPI*-*J* Japanese version of ten items of personality inventory^a^Two-sample *t*-test was performed for each sub-scale of TIPI-J. Statistical significance was set at less than 5%

Relationship Between the Neuroticism Trait and Duration of Non-visits {#Sec10}
---------------------------------------------------------------------

No significant correlation was found between the neuroticism score from TIPI-J and the duration of non-visits to ophthalmologists in the *Discontinued* group (*ρ* = 0.10, *P* = 0.16).

Discussion {#Sec11}
==========

In the present study, the authors have shown that the neuroticism trait, based on the Big Five personality traits as measured by the TIPI-J, was lower in the patients with GLC who discontinued their visits to ophthalmologists compared to those patients who continued to make regular visits.

Comparison of Sub-items from TIPI-J Between the *Discontinued* and *Regular Visitor* Groups {#Sec12}
-------------------------------------------------------------------------------------------

The mean neuroticism score from the TIPI-J in the *Discontinued* group was found to be significantly lower than that in the *Regular Visitor* group, while no significant difference was found in the scores from the other sub-items. Individuals with high neuroticism, or a tendency to experience negative emotions and emotional distress \[[@CR14]\], can have somatic sensitivity \[[@CR15]\] and worries about their health \[[@CR16]\]. In the current study, it is hypothesized that the *Discontinued* group could readily suspend their visits to ophthalmologists due to lower neuroticism than the *Regular Visitor* group.

Relationship Between the Neuroticism Trait and the Duration of Discontinued Visits to Ophthalmologists {#Sec13}
------------------------------------------------------------------------------------------------------

No significant correlation was found between the neuroticism score from the TIPI-J and the duration of non-visits to ophthalmologists in the *Discontinued* group. Thus, the authors suggest that the lack of correlation is due to the fact that the range of neuroticism trait in patients with GLC decides whether they are regular visitors or not.

Neuroticism as a Target for Continuation of Topical GLC Medications {#Sec14}
-------------------------------------------------------------------

The results of the study indicate that neuroticism could be an important target for treatment of GLC. Neuroticism itself can be an auxiliary target to treat the pathophysiology of GLC. High neuroticism can not only be a risk for mortality in coronary heart disease \[[@CR17]\] and a predictor of blood pressure \[[@CR18]\], but also a possible cause of fluctuations of intraocular pressure \[[@CR1]\]. This indicates that psychotherapeutic intervention for high neuroticism could stabilize intraocular pressure.

Neuroticism can also be a marker by which ophthalmologists change their approach to gain adherence to topical GLC medications. In the present study, low neuroticism predicts discontinuation to visit ophthalmologists, and, because individuals with high neuroticism can be sensitive to negative emotions, providing them with prognostic information from an optimistic aspect (e.g., this medication will prevent 30% of patients with GLC from going blind) might help them to regularly visit ophthalmologists. As for individuals with low neuroticism, prognostic information from a pessimistic aspect (e.g., 70% of patients will go blind even if they receive this medication) might encourage them to regularly visit ophthalmologists.

Study Limitation {#Sec15}
----------------

The current study has some limitations. First, stratification by age and gender was not enough to avoid sampling bias between the *Discontinued* and *Regular Visitor* groups. Due to lack of a control group, a referential neuroticism personality trait score could not be provided. Studies that include a control group are needed. Second, although the findings of the current study could have implications for the adherence of patients to topical GLC medications, the study did not directly measure adherence and persistence, meaning that the effect of the neuroticism personality trait on GLC medication needs further study. Third, as the definition of 'discontinuation' in the current study included participants who simply forgot to visit to their ophthalmologists, this could lead to a selection bias that could overestimate the duration of the discontinuation in the *Discontinued* group. Further studies would need to include a stricter definition for 'discontinuation.' Fourth, diagnosis, type of GLC, and prescription was self-reported by the participants, and, therefore, the accuracy of the data obtained was not independently validated by the authors.

Conclusions {#Sec16}
===========

In this study, the authors showed that neuroticism trait in patients with GLC who have discontinued visiting their ophthalmologists was lower than that in patients who visited them regularly, on the basis of the Big Five personality traits as measured by the TIPT-J.
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